![Frontiers | Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management Frontiers | Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management](https://www.frontiersin.org/files/Articles/713700/fendo-12-713700-HTML/image_m/fendo-12-713700-g001.jpg)
Frontiers | Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
![PDF) Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: A review PDF) Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: A review](https://i1.rgstatic.net/publication/26831467_Long-term_efficacy_and_safety_of_letrozole_for_the_adjuvant_treatment_of_early_breast_cancer_in_postmenopausal_women_A_review/links/0f60d4a53829fa8c64e5958f/largepreview.png)
PDF) Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: A review
![Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial - The Lancet Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/asset/dce59041-02e0-46a0-8486-22f28fb609b0/gr1.jpg)
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial - The Lancet
![Additional 5 Years of Letrozole May Benefit Some Postmenopausal Women With Early-Stage Breast Cancer - The ASCO Post Additional 5 Years of Letrozole May Benefit Some Postmenopausal Women With Early-Stage Breast Cancer - The ASCO Post](https://ascopost.com/media/14001996/710-3_image.jpg)